Author:
Aktas Orhan,Albrecht Philipp,Hartung Hans-Peter
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Neurology (clinical),Neurology
Reference53 articles.
1. MRI monitoring of immunomodulation in relapse-onset multiple sclerosis trials. Nature reviews;Barkhof;Neurology,2012
2. B cells in MS and NMO: pathogenesis and therapy;Krumbholz;Semin Immunopathol,2014
3. Atacicept in multiple sclerosis (ATAMS): a randomised, placebo-controlled, double-blind, phase 2 trial. The Lancet;Kappos;Neurology,2014
4. Repeated subcutaneous injections of IL12/23 p40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: a phase II, double-blind, placebo-controlled, randomised, dose-ranging study;Segal;Lancet Neurology,2008
5. ATON: results from a Phase II randomized trial of the B-cell-targeting agent atacicept in patients with optic neuritis;Sergott;J Neurol Sci,2015
Cited by
39 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献